Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 361-366

  Cao, Huibi ^a   Girard Globa, Anik ^a,b   Serusclat, André ^c   Bernard, Sophie ^c   Bondon, Pierre ^c   Picard, Sylvie ^c   Berthezene, François ^c   Moulin, Philippe ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b CNRS   (France)

^c Hopital de l'Antiquaille   (France)

Author keywords

Intima media thickness; LDL oxidizability; Lp(a); Non insulin dependent diabetes; Paraoxonase genotype

Indexed keywords

ARYLESTERASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; FEMALE; GENOTYPE; HUMAN; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGE FACTORS; ALLELES; ARYLDIALKYLPHOSPHATASE; BLOOD PRESSURE; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; ESTERASES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0032102149     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00031-8     Document Type: Article

References (27)

1. Ruiz J., Blanché H., James R.W.et al. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
2. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos. 19:1991;100-106.
3. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS. 286:1991;152-154.
4. Watson A.D., Berliner J.A., Hama S.Y.et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 96:1995;2882-2891.
5. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
6. Primo Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON 1) is one member of a multigene family genomics. 1996;33:498-507.
7. Clendenning J.B., Humbert R., Green E.D., Wood C., Traver D., Furlong C.E. Structural organization of the human PON1 gene. Genomics. 35:1996;586-589.
8. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 3:1993;73-76.
9. Adkins S., Gan K.N., Mody M., La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet. 52:1993;598-608.
10. Blatter-Garin M.C., James R.W., Dussoix P.et al. Paraoxonase polymorphism Met-Leu 54 is associated with modified concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest. 99:1997;62-66.
11. McElveen J., Mackness M.I., Colley C.M., Peard T., Warner S., Walker C.H. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem. 32:1986;671-683.
12. Secchiero S., Mussap M., Zaninotto M., Bertorelle R., Burlina A. Serum arylesterase (paraoxonase) activity folllowing myocardial infarction. Clin Chim Acta. 183:1989;71-76.
13. Serrato S., Marian A.J. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest. 96:1995;3005-3008.
14. Antikainen M., Murtomäki S., Syvänne M.et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest. 98:1996;883-885.
15. Herrmann S.M., Blanc H., Poirier O.et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis. 126:1996;299-303.
16. Suehiro T., Nakauchi Y., Yamamoto M.et al. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int J Cardiol. 57:1996;69-73.
17. Sanghera D.K., Saha N., Aston C.E., Kamboh M.I. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 17:1997;1067-1073.
18. Odawara M., Tachi Y., Yamashita K. Paraoxonase polymorphism (Gln 192-Arg) is associated with coronary heart disease in Japanese non insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 82:1997;2257-2260.
19. Wikstrand J., Wiklund O. Frontiers in cardiovascular science: quantitative measurements of atherosclerotic manifestations in humans. Arterioscler Thromb Vasc Biol. 12:1992;114-119.
20. Salonen JT, Salonen R. Arterial wall thickness, carotid atherosclerosis and the risk of myocardial infarction and cerebrovascular stroke. In: Touboul PJ, Crouse III JR. editors. Intima-Media Thickness and Atherosclerosis. The Parthenon Publishing Group, 1997.
21. Castellano M., Muiesan M.L., Rizzoni D.et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation. 91:1995;2721-2724.
22. Tsujino T., Kodama M., Watarai T., Kajimoto Y., Yamasaki Y., Hori M. ACE gene polymorphism and arteriosclerosis in Japanese NIDDM patients. Diabetologia. 40(suppl 1):1997;21.
23. Picard S., Talussot C., Serusclat A., Ambrosio N., Berthezene F. Minimally oxidised LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy. Diabetes Metab Paris. 22:1996;25-30.
24. ARIC study Investigators, Iribarren C., Folsom A.R., Jacobs D.R., Gross M.D. Jr., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;1171-1177.
25. Mackness B, Hunt R, Durrington PN, Mackness MI. increased immunolocalization of parraoxonase, clusterin, and apolipoprotein A-I in the human artery with the progression of atherosclerosis. 1997;17:1233-38.
26. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol. 15:1995;89-95.
27. Hegele R.A., Breckenridge W.C., Brunt J.H., Connelly P.W. Arterioscler Thromb Vasc Biol. 17:1997;1701-1706.